Recruiting
A Study of Romiplostim N01 as the First-line Treatment for Newly Diagnosed Adult Patients With ITP
NCT06658834
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
- Locations
-
- Chinese Academy of Medical Science and Blood Disease Hospital Tianjin, Tianjin Municipality, China